Diag-Nose.io Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.95M

  • Investors
  • 13

Diag-Nose.io General Information

Description

Operator of a precision medicine platform intended to improve the diagnosis and treatment of chronic nasal disorders. The company combines protein biomarkers, digital biomarkers, and multivariate algorithms to create actionable clinical insights for patients with chronic sinusitis and provides diagnostic clarity around overlapping sinonasal conditions, enabling physicians to administer the appropriate treatment, monitor efficacy, and reduce unnecessary interventions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Acacia Place
  • Notting Hill, Victoria 3168
  • Australia
+61 0449
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 1 Acacia Place
  • Notting Hill, Victoria 3168
  • Australia
+61 0449

Diag-Nose.io Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Diag-Nose.io Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 08-Sep-2025 $1.95M Completed Generating Revenue
7. Seed Round 30-Jan-2025 Completed Generating Revenue
6. Grant 19-Aug-2024 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Accelerator/Incubator 28-Jun-2023 Completed Startup
2. Seed Round 01-Mar-2021 $542K $632K Completed Startup
1. Accelerator/Incubator 01-Jan-2020 $89.6K $89.6K Completed Startup
To view Diag-Nose.io’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Diag-Nose.io Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a precision medicine platform intended to improve the diagnosis and treatment of chronic nasal disorders. Th
Other Devices and Supplies
Notting Hill, Australia
33 As of 2025

New York, NY
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Diag-Nose.io Competitors (2)

One of Diag-Nose.io’s 2 competitors is Volastra, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Volastra Venture Capital-Backed New York, NY
Illumina Formerly VC-backed San Diego, CA
You’re viewing 2 of 2 competitors. Get the full list »

Diag-Nose.io Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Diag-Nose.io Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cooperative Research Centres Projects Government
Breakthrough Victoria Venture Capital Minority
Angel (individual) Minority
Radar Ventures (Australia) Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 13 investors. Get the full list »

Diag-Nose.io FAQs

  • When was Diag-Nose.io founded?

    Diag-Nose.io was founded in 2020.

  • Where is Diag-Nose.io headquartered?

    Diag-Nose.io is headquartered in Notting Hill, Australia.

  • What is the size of Diag-Nose.io?

    Diag-Nose.io has 33 total employees.

  • What industry is Diag-Nose.io in?

    Diag-Nose.io’s primary industry is Other Devices and Supplies.

  • Is Diag-Nose.io a private or public company?

    Diag-Nose.io is a Private company.

  • What is Diag-Nose.io’s current revenue?

    The current revenue for Diag-Nose.io is .

  • How much funding has Diag-Nose.io raised over time?

    Diag-Nose.io has raised $2.59M.

  • Who are Diag-Nose.io’s investors?

    Cooperative Research Centres Projects, Breakthrough Victoria, , Radar Ventures (Australia), and are 5 of 13 investors who have invested in Diag-Nose.io.

  • Who are Diag-Nose.io’s competitors?

    Volastra and Illumina are competitors of Diag-Nose.io.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process